Relationship between individual radiosensitivity and radiation encephalopathy of nasopharyngeal carcinoma after radiotherapy

Strahlentherapie und Onkologie

Volumn 184, Issue 10, 2008, Pages 510-514

  Tang, Yamei ^a   Zhang, Yinyin ^a   Guo, Ling ^b   Peng, Ying ^a   Luo, Qingliang ^a,c   Xing, Yigang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Chromosomal aberration rate; Nasopharyngeal carcinoma; Radiation encephalopathy; Radiosensitivity

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DISEASE; CANCER GRADING; CANCER RADIOTHERAPY; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MORBIDITY; NASOPHARYNX CARCINOMA; RADIOSENSITIVITY; RISK FACTOR; SCORING SYSTEM;

ADULT; AGED; BRAIN; BRAIN DAMAGE, CHRONIC; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RISK;

EID: 56549108750     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1898-z     Document Type: Article

References (16)

1. Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiother Oncol 2002;64:131-40.
2. Barber JB, Burrill W, Spreadborough AR, et al. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol 2000;55:179-86.
3. Borgmann K, Roper B, El-Awady R, et al. Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol 2002;64:141-52.
4. Capalbo G, Rödel C, Stauber RH, et al. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlenther Onkol 2007;183:593-9.
5. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
6. Hoeller U, Borgmann K, Bonacker M, et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 2003;69:137-44.
7. Malone S, Raaphorst GP, Gray R, et al. Enhanced in vitro radiosensitivity of skin fibroblasts in two patients developing brain necrosis following AVM radiosurgery: a new risk factor with potential for a predictive assay. Int J Radiat Oncol Biol Phys 2000;47:185-9.
8. Papworth R, Slevin N, Roberts SA, et al. Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients. Br J Cancer 2001;84:776-82.
9. Perez A, Grabenbauer GG, Sprung CN, et al. Potential for the G2/M arrest assay to predict patient susceptibility to severe reactions following radiotherapy. Strahlenther Onkol 2007;183:99-106.
10. Raaphorst GP, Malone S, Alsbeih G, et al. Skin fibroblasts in vitro radiosensitivity can predict for late complications following AVM radiosurgery. Radiother Oncol 2002;64:153-6.
11. Rudat V, Dietz A, Nollert J, et al. Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 1999;53:233-45.
12. Scott D. Chromosomal radiosensitivity, cancer predisposition and response to radiotherapy. Strahlenther Onkol 2000;176:229-34.
13. Smart V, Curwen GB, Whitehouse CA, et al. Chromosomal radiosensitivity: a study of the chromosomal G(2) assay in human blood lymphocytes indicating significant inter-individual variability. Mutat Res 2003;528:105-10.
14. Strasser H, Grabenbauer GG, Sprung CN, et al. DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients. Strahlenther Onkol 2007;183:447-53.
15. Turesson I, Nyman J, Holmberg E, et al. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065-75.
16. Varga D, Vogel W, Bender A, et al. Increased radiosensitivity as an indicator of genes conferring breast cancer susceptibility. Strahlenther Onkol 2007;183:655-60.